The Joe Rogan ExperienceJoe Rogan Experience #2420 - Chris Masterjohn
CHAPTERS
- 0:00 – 2:43
Thanksgiving food coma myth: turkey, tryptophan, and why overeating makes you sleepy
They kick off by debunking the classic claim that turkey’s tryptophan causes post-Thanksgiving drowsiness. Masterjohn explains the journalistic origin of the myth and why the physiology of a large meal better explains the fatigue.
- •Tryptophan myth traced to 1980s media explanations
- •Turkey isn’t uniquely high in tryptophan (whey can be higher)
- •Eating turkey alone won’t ‘knock you out’—meal size matters
- •Parasympathetic ‘rest and digest’ response after a feast
- •Animal analogy: hunters alert when hungry, sleepy after eating
- 2:43 – 5:05
Mitochondria as the root of health: sleep, energy restoration, and creatine as a ‘power grid’
Masterjohn frames mitochondrial function as central to health and aging, using sleep as an example of downshifting metabolism to restore energy reserves. He connects this to a study where creatine reduced the cognitive cost of sleep deprivation.
- •Deep sleep as a period of lowered metabolic demand to restore energy
- •Mitochondria produce ATP; energy management underpins repair/maintenance
- •Creatine study: 20g during an all-nighter improved puzzle performance and reduced fatigue
- •Creatine described as energy distribution system inside cells
- •Concept: supporting energy distribution can buffer sleep deprivation effects
- 5:05 – 7:43
Creatine beyond muscles: brain injury recovery and whole-body roles
They explore how creatine is present in nearly all tissues and may support functions well beyond hypertrophy. Masterjohn notes emerging brain/TBI findings and explains why creatine’s ubiquity suggests broader systemic benefits.
- •Creatine system exists in most cells, not just muscle
- •Potential relevance to retina and long neural cells (energy shuttling)
- •TBI literature: 20g creatine for months may accelerate healing
- •Why benefits show up as research expands beyond sports performance
- •Open question: limited direct trials on eyesight outcomes
- 7:43 – 10:46
Red light therapy, macular health supplements, and nutrient sources (lutein/zeaxanthin, egg yolks)
Rogan shares improvements in macular degeneration after using a red light bed and macular-support supplements. Masterjohn links red/near-infrared light to mitochondrial energy production and discusses food-based sources of key eye nutrients.
- •Red/near-infrared light acts directly on mitochondrial energy machinery
- •Study hint: red light to the chest improved vision next day even with eyes covered
- •Lutein/zeaxanthin accumulate in the macula and protect against degeneration
- •Egg yolks (especially from marigold-fed chickens) as a highly bioavailable source
- •Absorption synergy: fat in egg yolk aids uptake
- 10:46 – 13:13
Vitamin A conversion, antioxidants, and glutathione: ‘make it yourself’ vs specialty forms
They review the logic behind ingredients in eye-support stacks and pivot to glutathione. Masterjohn emphasizes upstream nutrition (protein intake and endogenous synthesis) and questions whether pricier delivery systems provide proportional benefit.
- •Vitamin A needs depend on beta-carotene conversion efficiency
- •Conversion influenced by zinc, iron, thyroid status—and reduced by seed oils
- •Antioxidants discussed: vitamin C, NAC, glutathione
- •Best glutathione is endogenous production from dietary protein
- •Liposomal/special forms may offer marginal gains but often poor value
- 13:13 – 16:45
Sunlight, vitamin D, and light substitutes: morning cues, tanning beds, and light boxes
Masterjohn distinguishes vitamin D from broader benefits of sun exposure, especially morning light for circadian/mitochondrial signaling. They discuss pragmatic options for low-sun environments, including careful tanning bed use and bright-light therapy.
- •Sunlight provides benefits beyond vitamin D supplementation
- •Morning outdoor light as a wake-up signal for metabolic/mitochondrial ramp-up
- •Afternoon sun for vitamin D, but balance burn risk
- •Tanning bed use: minimal exposure, focus on UVB if seeking vitamin D
- •Light therapy boxes and lux-meter checks for cloudy locations
- 16:45 – 23:35
Methylene blue: when mitochondrial ‘detours’ help—and when they create chaos
Rogan asks about methylene blue’s hype and risks. Masterjohn argues it can be powerful for specific mitochondrial blockages but harmful when unnecessary, explains its redox-cycling mechanism, and stresses testing-guided use.
- •Methylene blue can help mitochondrial dysfunction but harm healthy function
- •Selection bias: ‘success stories’ dominate online chatter
- •At ~10mg/day it can act like an MAO-inhibiting antidepressant
- •Mechanism: redox cycling shuttles electrons, creating alternate pathways
- •Animal data: can reduce ATP in healthy cases but rescue ATP under inhibition
- 23:35 – 26:49
Aging as mitochondrial decline: the 1% per year model and controllable variability
They broaden the conversation to aging and why mitochondrial function appears to decline across adulthood. Masterjohn presents the idea that aging and mitochondrial dysfunction are tightly linked, but that lifestyle and variability matter tremendously.
- •Claim: mitochondrial dysfunction and aging are closely intertwined
- •Average decline cited: ~1% mitochondrial function per year from ~18 onward
- •By ~70, average baseline energy capacity may be ~50% of youth baseline
- •Only part of mitochondrial function is explained by age; large individual spread
- •Goal: maximize mitochondrial function at each age to slow functional decline
- 26:49 – 34:13
Five pillars for mitochondria: creatine, sunlight, nutrition, exercise, and individualized testing
Masterjohn lays out broad, actionable levers to support mitochondrial health while emphasizing personalization via testing. He offers practical rules of thumb for creatine intake, sunlight timing, nutrient density, and protein-centered meals.
- •Creatine: most non–high-meat eaters likely benefit from supplementation
- •Sunlight: morning exposure plus red/IR benefits; devices as add-ons
- •Nutrition: deficiencies common; prioritize nutrient-dense whole foods
- •Nose-to-tail animal foods, diversify proteins (fish/shellfish/dairy if tolerated)
- •Home-prepped meals and digestion quality as foundational
- 34:13 – 50:08
Exercise for longevity: why gymnasts and pole vaulters may outlive endurance athletes
They discuss different exercise modalities and the surprising longevity data suggesting gymnasts and pole vaulters live longer than many other pro athletes. Masterjohn hypothesizes that whole-body function, skill, and mechanical tissue health may matter beyond VO2 max.
- •Endurance boosts muscle mitochondrial density, but strength/sprints may train liver metabolism
- •Longevity should include strength, mobility, agility, balance, proprioception, reaction time
- •Observational finding: gymnasts/pole vaulters +8 years vs general population; cyclists +2
- •Speculation: functional mechanics and stretching may influence immune/tumor environments
- •Avoid overly narrow optimization (e.g., only VO2 max)
- 50:08 – 56:15
Skill training and ‘don’t lose your gains’: new sports, coordination, and daily maintenance habits
They connect skill-based movement to brain health and aging, then get practical about identifying weaknesses via new sports. Masterjohn describes building small daily ‘maintenance’ practices (rolls, jump rope) to preserve abilities while pursuing new goals.
- •Skill + strategy + reaction time offer cognitive and neurological training benefits
- •Trying new sports reveals blind spots (rotation, agility, vestibular tolerance)
- •Daily minimums to retain skills (e.g., rolls, jump rope sets)
- •Balancing achievement with retention to avoid repeated loss of capacity
- •Training across planes of movement (rotation/side-bending) often neglected
- 56:15 – 1:02:27
Injuries, overtraining, and brain trauma: systemic energy costs and recovery strategies
They examine how repeated injuries (and concussion) can impose long-term metabolic costs, not just localized damage. Masterjohn ties recovery to energy availability and highlights creatine and targeted testing as potential tools for traumatic brain injury support.
- •Injury prevention prioritized for longevity and performance progression
- •Cumulative ‘repair tax’ may contribute to long-term decline
- •Concussions: brain’s outsized energy demand makes recovery system-wide
- •Creatine as one evidence-backed option in brain injury contexts (often ~20g in studies)
- •Testing and bottleneck identification to maximize recovery windows
- 1:02:27 – 1:24:19
Food-first, pharma-last: CoQ10 dosing, heart as a food source, and megadose cautionary tales
Masterjohn outlines his hierarchy: fix diet first, then consider supplements strategically, and reserve drugs for when needed on a strong foundation. He contrasts CoQ10’s mainstream trial base with variable dose responses, shares an extreme success case, and warns about megadosing nutrients like thiamine without monitoring.
- •CoQ10 found in food (especially heart) and synthesized in the body; not ‘like methylene blue’
- •Trial pattern: benefits often at ~100–200mg/day; higher doses can backfire for some
- •Case example: high-dose CoQ10 (~700–800mg) restoring menses after long amenorrhea (testing-guided)
- •Megadose risks: high-dose thiamine example causing worsening symptoms and motor issues
- •Home monitoring idea: glucose/ketones/lactate as feedback for mitochondrial stress vs improvement
- 1:24:19 – 1:43:34
Seed oils controversy: long trials, tissue vulnerability, oxidation, and cholesterol narrative fallout
They tackle why seed oils remain contentious and why short trials may miss long-term harm. Masterjohn cites older multi-year RCTs and proposes a mechanism where high-PUFA oils make tissues (and LDL particles) more prone to oxidative damage, affecting cancer and atherosclerosis outcomes over time.
- •Core claim: seed oils increase vulnerability to damage rather than directly ‘damaging’ immediately
- •Short trials (weeks) vs older RCTs (5–8 years) create misleading conclusions
- •LA Veterans study: early heart disease signal fades; cancer divergence emerges after years
- •Tissue turnover: fatty-acid composition can take years to reflect dietary change
- •Oxidized PUFAs in lipoproteins drive immune sequestration and plaque formation
- 1:43:34 – 1:59:03
Cholesterol, thyroid, and abundance signaling: metabolism as the missing lens
They revisit cholesterol fear, arguing that cholesterol’s role depends on metabolic context and usage. Masterjohn emphasizes thyroid/abundance signaling and mitochondrial energy as drivers of cholesterol turnover, and critiques interventions that ignore underlying energy metabolism.
- •Cholesterol is essential (hormones, bile acids, brain synapses) but high levels can signal poor utilization
- •Prospective data: higher cholesterol in youth predicts later heart risk—possibly as sluggish metabolism marker
- •Seed oils may lower blood cholesterol yet worsen plaque via oxidizable LDL membranes
- •Thyroid hormone historically used to lower cholesterol; risk is overdosing/false abundance signaling
- •Statins framed as mitochondrial toxins (incl. reduced CoQ10 synthesis), raising foundation-first concerns
- 1:59:03 – 2:05:43
Thyroid support basics: protein, iodine variability, selenium/antioxidants, and modern deficiency traps
In response to thyroid questions, Masterjohn emphasizes dietary prerequisites (protein/tyrosine and iodine) and why iodine intake is inconsistent due to soil geography. He also discusses competing halogens (bromine/fluoride), selenium’s role in thyroid antioxidant defense, and how low-salt guidance undermined iodized salt strategies.
- •Thyroid hormone built from tyrosine (protein) plus iodine
- •Iodine content varies widely in land foods; seafood and seaweed are more reliable
- •Personal strategy: small daily kelp powder to self-fortify
- •Environmental bromine and fluoride can increase iodine requirements
- •Selenium supports glutathione-based thyroid protection; broader antioxidant nutrient support matters
- 2:05:43 – 2:19:26
Nattokinase and event risk: clot breakdown, plaque rupture, and why natto may be the better ‘package’
They close with nattokinase as a clot-degrading enzyme and clarify that most heart attacks/strokes are triggered by clotting after plaque rupture, not simple arterial blockage. Masterjohn notes natto’s additional K2 content and returns to the food-first principle as the more complete intervention.
- •Most acute events arise from plaque rupture + clot formation, not pure occlusion
- •Inflammation and oxidative processes weaken plaque caps, enabling micro-tears
- •Nattokinase helps break down clots; may lower acute event risk in high-clotting individuals
- •Natto provides nattokinase plus vitamin K2, supporting plaque stability via calcium handling
- •Trade-off: reduced clotting can raise bleeding risk; context matters
